SCR 12 is a California Senate Concurrent Resolution that commends certified registered nurse anesthetists (CRNAs) for their clinical expertise and designates January 19–25, 2025, as National CRNA Week. The resolution highlights CRNAs’ training, work across rural, urban, military and underserved settings, and their role in promoting opioid‑free and opioid‑sparing anesthesia and pain‑management techniques.
Because this is a concurrent resolution, it carries no regulatory authority or funding; its primary effect is symbolic. Still, the text signals legislative attention to CRNAs’ contributions to workforce capacity and opioid‑reduction strategies, which stakeholders can use for advocacy, public messaging, and aligning local clinical initiatives with state recognition.
At a Glance
What It Does
The resolution formally praises CRNAs, describes their training and clinical roles, and declares the week of January 19–25, 2025, as National CRNA Week. It contains multiple 'whereas' findings that emphasize opioid‑free and opioid‑sparing techniques and asks the Secretary of the Senate to transmit copies to the author for distribution.
Who It Affects
The text directly names and honors certified registered nurse anesthetists across California and references hospitals, rural clinics, military settings, and underserved communities where CRNAs practice. Indirectly it touches professional associations, nursing schools, and policymakers focused on opioid policy and workforce planning.
Why It Matters
Although ceremonial, the resolution codifies legislative recognition of CRNAs’ role in opioid‑reduction strategies and workforce access, creating a public record stakeholders can cite in advocacy, recruitment, and grant applications. It also frames CRNAs as part of the state’s response to the opioid crisis, which can shape policy conversations without changing statutes or reimbursement.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SCR 12 is a short, nonbinding concurrent resolution that collects factual statements about certified registered nurse anesthetists and then resolves to commend them and declare a week in their honor. The measure assembles multiple 'whereas' clauses that restate CRNAs’ education, clinical scope, geographic reach, and the specific techniques they use—multimodal anesthesia, regional blocks, and nonopioid medications—to reduce opioid exposure.
After the preamble, the operative language is narrow: the Legislature 'commends' CRNAs, 'acknowledges' their role in promoting opioid‑free and opioid‑sparing care, and 'joins in celebrating' National CRNA Week 2025. The resolution includes an administrative direction asking the Secretary of the Senate to send copies of the resolution to the author for distribution.
The text also notes that the measure had no fiscal committee requirement, reflecting its ceremonial nature.Practically, the resolution does not amend state law, change professional scope of practice, alter licensing, or create funding streams. Its utility lies in signaling state policy priorities and validating the profession’s contributions—language that professional groups can cite when seeking grants, educational partnerships, or attention to workforce shortages.
It also ties CRNA practice explicitly to strategies aimed at reducing opioid dependence, which may be referenced in future regulatory or funding discussions even though the resolution itself imposes no requirements.
The Five Things You Need to Know
SCR 12 designates January 19–25, 2025, as National CRNA Week in California and formally commends certified registered nurse anesthetists.
The resolution’s 'whereas' clauses enumerate CRNAs’ advanced training and their use of opioid‑free, opioid‑sparing, and nonopioid pain‑management techniques (e.g.
multimodal anesthesia, regional blocks, NSAIDs).
SCR 12 explicitly cites CRNAs’ work in urban centers, rural hospitals, military settings, and underserved communities as part of California’s healthcare delivery.
The measure is a concurrent resolution—ceremonial and nonbinding—and contains a fiscal committee notation indicating no fiscal effect.
The Legislature directs the Secretary of the Senate to transmit copies of the resolution to the author for appropriate distribution, creating an official document for outreach and advocacy.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings on CRNA training, settings, and clinical techniques
This section strings together factual statements describing CRNAs’ academic and clinical training, the clinical settings where they practice, and the specific opioid‑reduction techniques they use. For practitioners and analysts, these clauses are a concise catalog of the professional roles and clinical approaches the Legislature intends to highlight—useful for citation but carrying no regulatory weight.
Legislature commends CRNAs and recognizes opioid‑sparing role
The first operative clause commends CRNAs for expertise, dedication, and service, and acknowledges their role in promoting opioid‑free and opioid‑sparing pain‑management strategies. Legally, 'commends' and 'acknowledges' are declaratory; they do not create obligations, but they place the Legislature on record associating CRNAs with opioid‑reduction efforts.
Designation of National CRNA Week
This clause declares January 19–25, 2025, as National CRNA Week. The declaration is purely symbolic but establishes a specific date window that professional organizations and healthcare institutions can leverage for events, awareness campaigns, and recruitment drives.
Transmittal instruction to Secretary of the Senate
The resolution instructs the Secretary of the Senate to transmit copies to the author for distribution. This is a routine administrative step that ensures official copies circulate to stakeholders, associations, and the public; it is the mechanism that turns the ceremonial language into tangible outreach materials.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Certified registered nurse anesthetists (CRNAs): The resolution gives formal legislative recognition that organizations and individuals can cite in recruitment, public relations, and advocacy to bolster professional standing.
- Nursing schools and CRNA training programs: The public recognition can support outreach and enrollment efforts by highlighting the profession’s statewide importance and role in opioid‑reduction strategies.
- Professional associations (e.g., state CRNA societies): They gain an official state document to use in campaigns, grant applications, and dialogues with payers or hospitals about expanding services.
- Hospitals and rural clinics: Facilities can leverage the week and the resolution’s language for community outreach and to justify initiatives promoting opioid‑sparing protocols.
Who Bears the Cost
- Legislative staff and the Secretary of the Senate: They incur routine administrative time to prepare and distribute copies, though the fiscal note indicates no substantive budget impact.
- Health systems hosting recognition events: Any promotional or event costs associated with marking National CRNA Week fall to hospitals, clinics, or associations that choose to participate.
- Policymakers and regulators facing expectations: By publicly linking CRNAs to opioid‑reduction, the Legislature may raise expectations for follow‑on policy or funding, creating pressure on agencies without providing resources.
Key Issues
The Core Tension
The central tension is between symbolic recognition and substantive change: the Legislature signals support for CRNAs and opioid‑reduction strategies, which raises expectations for policy action, but the resolution itself provides no legal authority, funding, or implementation mechanism to turn recognition into concrete workforce or clinical outcomes.
SCR 12 is declarative: it records legislative praise and a date but does not change licensure, scope of practice, reimbursement, or funding. That creates a common implementation gap—stakeholders may treat the resolution as a policy signal and expect follow‑up (e.g., workforce investments, reimbursement changes) that the text does not authorize.
The measure emphasizes opioid‑sparing techniques and lists specific clinical approaches, but it offers no clinical guidance, standards, or monitoring; health systems must translate the language into protocols if they intend to act on it.
The resolution also risks simplifying complex clinical trade‑offs. Highlighting nonopioid techniques as a general good may understate situations where opioids remain the most effective option for acute pain.
Finally, while the text underscores CRNAs’ role in expanding access—especially in rural and underserved areas—it does not include workforce development measures, funding for education, or strategies to address retention and distribution, leaving those practical problems unresolved despite the public recognition.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.